Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.
about
Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammationCurrent perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaThe role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisHepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signalingChemical modification of proteins by lipids in diabetes.Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type MiceSoluble receptor for advanced glycation end products and risk of liver cancer.Impact of glucose levels on advanced glycation end products in hemodialysis.Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantationDiabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Senescence-dependent impact of anti-RAGE antibody on endotoxemic liver failureAGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis.What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?Advanced glycation end products and diabetic retinopathy.Galectin-3: an emerging all-out player in metabolic disorders and their complications.Diabetes mellitus in patients with cirrhosis: clinical implications and management.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression.Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report.Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver diseaseAdvanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis.Serum autofluorescence, a potential serum marker for the diagnosis of liver fibrosis in rats.Oxidative damage in the liver of rats treated with glycolaldehyde.Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats.Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.Increased protein glycation in cirrhosis and therapeutic strategies to prevent it.Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine.The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).Advanced glycation end products in myocardial reperfusion injury.
P2860
Q26745839-A8824BF4-78F9-48DD-8C21-F97CF2F693AAQ26781156-6823367D-7B70-4F51-BB9A-2EEDFAE74505Q26781477-942401C0-49DE-4E99-AE20-2C4EAFB3ACE1Q26797382-2A87F762-C548-458E-9319-E9CAA6242DC6Q33811776-118457D9-480A-46F4-9597-63D338D2EB29Q34409300-C96E64FC-B6C3-4006-9C0D-9B05F9CA213EQ35576075-0A598F9F-B92C-45D5-9C38-567E21C06053Q35583145-6A63FC30-A01F-40A9-9682-2B2BB2ACF6EAQ36578536-493B108E-8DB5-4C1C-8A6D-01EBC5A55F7AQ36816945-A48929C4-EEF6-4831-BC74-E5B0180436EAQ36852110-C3B853EE-E15E-42D8-80A7-111BA5BFB33CQ36915810-3C80DB12-84B8-47EC-A305-271DE9FEAC3FQ36916192-BC41E7E1-198F-4FA4-BE50-73705E0A4C80Q37072018-E67A04F3-A75D-4814-AD29-312D927DC46FQ37300540-6024E342-E11E-4732-AF37-ADC7BE06FC05Q37326771-E5D6F35F-5A7F-4DAB-A62F-4C0F8A2F6089Q37857797-BDA6E005-7907-460F-94B5-4AE1CC14C2A1Q38193463-1B9A1E3E-E797-4A21-A38A-BFA16F815264Q38258947-C0E95B6C-4E4F-44BC-AC26-CDC09A49BE98Q38773241-C6181DA9-ECE9-4284-8DF0-BFC67D0C0385Q39036315-6C2DE5E3-7C85-4005-AB06-6F46ED2F0FD7Q39332869-C1DEF104-9AB3-4446-8C8F-B20E4166BDE6Q40872573-8F4433E1-E3E2-49FD-8F65-C2DFB84115FFQ41134548-9C5EEF01-14C3-4F73-9D37-2249E5F8271BQ41206326-E511AC1C-836B-4321-881C-783A230D624CQ42250966-392E3511-BE8A-4F64-81C1-763D4909AA77Q42747339-704306C7-3A63-4D30-9B2B-985596B0D323Q43187791-21CFDBAC-A018-4032-94E0-9DDA39555864Q44401494-BB36C881-20D5-43A6-B656-2FE83C058F85Q46495572-9880B8AC-A4EA-4C25-9587-F039D0E3FBAEQ46613224-087647C6-991A-44B7-AB6F-44A6960B66E4Q46639089-BFEB3FE7-4559-4607-8DB4-089482E4A3B1Q47095662-A3259716-F751-40F4-82E6-15BE892CF17FQ51373390-B23A2C2F-9BF2-48E3-BE00-135EB51B017B
P2860
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Markedly elevated levels of pl ...... tion by liver transplantation.
@en
Markedly elevated levels of pl ...... tion by liver transplantation.
@nl
type
label
Markedly elevated levels of pl ...... tion by liver transplantation.
@en
Markedly elevated levels of pl ...... tion by liver transplantation.
@nl
prefLabel
Markedly elevated levels of pl ...... tion by liver transplantation.
@en
Markedly elevated levels of pl ...... tion by liver transplantation.
@nl
P2093
P1476
Markedly elevated levels of pl ...... ation by liver transplantation
@en
P2093
August Heidland
Reinhard Schinzel
Viera Kupcová
P356
10.1016/S0168-8278(01)00232-X
P50
P577
2002-01-01T00:00:00Z